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mTORC1 and PKB/Akt control the muscle response
to denervation by regulating autophagy
and HDAC4
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Loss of innervation of skeletal muscle is a determinant event in several muscle diseases.
Although several effectors have been identiﬁed, the pathways controlling the integrated
muscle response to denervation remain largely unknown. Here, we demonstrate that PKB/
Akt and mTORC1 play important roles in regulating muscle homeostasis and maintaining
neuromuscular endplates after nerve injury. To allow dynamic changes in autophagy,
mTORC1 activation must be tightly balanced following denervation. Acutely activating or
inhibiting mTORC1 impairs autophagy regulation and alters homeostasis in denervated
muscle. Importantly, PKB/Akt inhibition, conferred by sustained mTORC1 activation, abro-
gates denervation-induced synaptic remodeling and causes neuromuscular endplate degen-
eration. We establish that PKB/Akt activation promotes the nuclear import of HDAC4 and is
thereby required for epigenetic changes and synaptic gene up-regulation upon denervation.
Hence, our study unveils yet-unknown functions of PKB/Akt-mTORC1 signaling in the muscle
response to nerve injury, with important implications for neuromuscular integrity in various
pathological conditions.
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Skeletal muscle is a highly plastic tissue, whose functionstrictly depends on neural activity. Nerve injury leads tomuscle atrophy and to the remodeling of neuromuscular
junctions (NMJs) and non-synaptic muscle regions1–3. The
mechanisms underlying this integrated muscle response remain
poorly understood.
Denervation-induced muscle wasting involves the increased
activity of the ubiquitin/proteasome system, with an up-
regulation of atrogenes (e.g. Fbxo32 and Trim63) under the
control of class II histone deacetylase 4 (HDAC4) and forkhead
box O (FoxO) transcription factors4–8. FoxO activation is thought
to be a consequence of mTORC1- (mammalian Target of Rapa-
mycin Complex 1) induced inhibition of protein kinase B (PKB/
Akt), suggesting that mTORC1 activation promotes muscle
wasting upon denervation6. However, one report rather suggests
that mTORC1 activation limits denervation-induced muscle
atrophy, by promoting protein synthesis and inhibiting autop-
hagy9. Others suggested that both autophagy5,10,11 and PKB/
Akt12–15 are induced following denervation. Thus, the state and
the role(s) of PKB/Akt-mTORC1 signaling and autophagy after
nerve injury remain largely unknown.
In innervated muscle, acetylcholine receptors (AChRs) and
other synaptic proteins are selectively expressed and aggregate at
the NMJ. Upon denervation, AChRs are destabilized and their
synthesis increases, resulting in a strong increase in their turnover
rates16–22. In non-synaptic muscle regions, release of the repres-
sion of synaptic genes promotes ectopic AChR cluster forma-
tion23–26. HDAC4 induction and HDAC9 repression control the
underlying epigenetic and transcriptional changes following
denervation26–28. HDAC4 directly represses speciﬁc genes (e.g.
Pfkm, Eno3) and indirectly induces Myog (encoding the myogenic
factor myogenin), by repressing the genes encoding the co-
repressors Dach2 and HDAC9. In turn, myogenin induces both
synaptic genes and atrogenes8,27–29. However, the mechanisms
regulating HDAC4/9 in response to neural activity are unknown.
Here, we examine the role of mTORC1 and PKB/Akt in the
muscle response to denervation, focusing on muscle homeostasis
and synaptic changes. We report that mTORC1 activation is
tightly balanced upon denervation, thereby allowing the muscle-
speciﬁc, temporal changes in autophagic ﬂux necessary to
maintain muscle homeostasis. Simultaneously, PKB/Akt activa-
tion promotes HDAC4 nuclear import, to increase synaptic gene
expression and AChR turnover, processes that are essential to
maintain neuromuscular endplates after nerve injury.
Results
Denervation induces PKB/Akt and mTORC1 pathways in
muscle. To determine the state of PKB/Akt-mTORC1 signaling
after denervation, we performed Western blot analysis of tibialis
anterior (TA) muscle at different time points after sciatic nerve
cut. After 1 day of denervation, levels of the total and/or phos-
phorylated forms of mTOR and of the mTORC1 targets, ribo-
somal protein S6 kinase (p70S6K1), ribosomal protein S6 and 4E-
BP1, increased in TA muscle (Fig. 1a and Supplementary Fig. 1a).
mTORC1 signaling remained active in denervated muscle
throughout the 4 weeks of analysis. Active forms of S6 (S6P235/6
and S6P240) were enriched near some endplates in innervated
muscle and they further accumulated upon denervation (Fig. 1b
and Supplementary Fig. 1b, c). Levels of PKB/Akt and of its
active, phosphorylated forms (AktP473 and AktP308) were
unchanged before 3 days of denervation, but increased thereafter
in TA muscle (Fig. 1c). As Tang et al. (2014) previously reported
decreased levels of active PKB/Akt6, we conﬁrmed the speciﬁcity
of the phosphorylation at serine 473, by showing that it is lost in
denervated muscle from RImKO (Rictor muscle knockout) mice,
which are depleted of the PKB/Akt kinase mTOR complex 230. In
contrast to AktP473, both AktP308 and S6P235/6 levels were similar
in RImKO and control muscles (Supplementary Fig. 1d). Inter-
estingly, increased protein levels of PKB/Akt correlated with
transcriptional up-regulation of Akt1 at days 3 and 7 post-
denervation, while transcript levels of Akt2 and Akt3 were
unchanged (Fig. 1d, e). Denervation also increased transcript
levels of Mtor and Rptor, but not of Rps6 (Fig. 1f, g). In TSCmKO
(TSC1 muscle knockout) mice, which are depleted of
the mTORC1 inhibitor TSC1 in skeletal muscle31,32,
mTORC1 signaling was active in both innervated and denervated
muscles (Fig. 1a). Moreover, activation of PKB/Akt was low in the
mutant denervated muscle (Fig. 1c), in line with the negative
feedback from mTORC1 onto PKB/Akt31,32. Notably, up-
regulation of Akt1, Mtor and Rptor was blunted in TSCmKO
denervated muscle (Fig. 1d-g), suggesting deregulation of addi-
tional upstream mechanisms in mutant muscle. Together, these
results point to an early transcriptional induction and a strong
activation of both mTORC1 and PKB/Akt in muscle after nerve
injury. Of note, denervation caused only minor changes in
mTORC1 and PKB/Akt signaling in slow soleus muscle of control
mice (Fig. 1h), consistent with observations made by others6.
Denervation triggers myopathic alterations in TSCmKO
muscle. We next investigated whether a sustained activation of
mTORC1, by using TSCmKO mice, would affect the muscle
response to denervation. Loss of mass in mutant and control mice
was similar for TA muscle after 1 month of denervation, but
exacerbated in the soleus muscle from TSCmKO mice, as com-
pared to control (Fig. 2a). Accordingly, the size of type IIB ﬁbers
was similarly reduced in control and TSCmKO muscles upon
denervation, while atrophy of type IIA/X and I ﬁbers in TA and
soleus muscles was stronger in TSCmKO mice than in controls
(Fig. 2b–d and Supplementary Fig. 2a-c). Notably, the seeming
resistance of soleus control muscle to denervation-induced atro-
phy (Fig. 2a) is likely based on changes in non-muscle tissue, as
the mean ﬁber feret was similarly decreased in soleus and TA
muscles after 28 days of denervation (−19.7 ± 2.1% in TA vs.
−22.2 ± 5.7% in soleus, mean ± s.e.m). In TA control muscle,
denervation caused a major shift in the ﬁber type proportion,
from type IIB ﬁbers to slower ﬁbers expressing myosin heavy
chains (MHC) IIA/X (Fig. 2e, f), as has been reported by
others28,33. In contrast, denervation led to a major loss of type
IIA/X ﬁbers and a gain in type IIB ﬁbers in TA (Fig. 2e, f), and
even more strikingly, in soleus (Supplementary Fig. 2d, e) muscles
of TSCmKO mice. Denervation also resulted in the appearance of
some embryonic MHC (eMHC)-positive ﬁbers in TSCmKO
muscle, indicating ongoing degeneration/regeneration (Supple-
mentary Fig. 2f, g).
Most intriguingly, 4 weeks of denervation triggered a severe
myopathy in 3-month-old TSCmKO mice, reminiscent to the
changes reported for 9–10 months-old TSCmKO mice32.
Characteristic features of the myopathy were the accumulation
of vacuoles, aggregates and abnormal nuclei in muscle ﬁbers
(Fig. 2g, h and Supplementary Fig. 2h, i). Lamin and Dapi
staining conﬁrmed the presence of swollen nuclei and suggested
that some of the large vacuoles derived from nuclear vacuoliza-
tion (Fig. 2i and Supplementary Fig. 2j). Nucleoli of giant nuclei
were also larger or displayed abnormal shape, suggestive of
excessive ribosome biogenesis9,34 (Fig. 2i and Supplementary
Fig. 2j). Moreover, some nuclei were TUNEL-positive, indicating
DNA damage (Fig. 2j, k). However, there was no increase in the
number of cleaved caspase3-positive cells or in the levels of
endonuclease G35 (Supplementary Fig. 2k-m), suggesting that
TUNEL-positive nuclei are not dependent on these apoptotic
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pathways. Expression of Gadd45, which has been associated with
myonuclear remodeling36, was slightly higher in innervated
TSCmKO muscle, compared to controls. However, Gadd45 levels
were similarly increased in mutant and control muscles after
denervation (Supplementary Fig. 2n, o), suggesting that Gadd45
is not responsible for the nuclear changes in TSCmKO muscle.
Lastly, immunostaining against modiﬁed histones (acetylated
H3/H4 and methylated H3K4) was weak or even absent in
vacuolated nuclei (Fig. 2l), suggesting that aberrant permissive
epigenetic changes are also not causative to the nuclear swelling.
Altogether, these results indicate that sustained mTORC1
activation alters the muscle response to denervation, and they
show that denervation precipitates the deleterious effects of
sustained mTORC1 activation on muscle homeostasis.
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Fig. 1 The PKB/Akt-mTORC1 branch is induced upon denervation in TA muscle. a Western blot analysis of mTORC1 signaling in control (Ctrl) and
TSCmKO (TSC) TA innervated (In) and denervated (De) muscles. Actinin was used as loading control. Representative image of 4 (14 h, 1d) and 3 (3 to
28d) Ctrl and 3 TSCmKO mice. b Confocal images of S6P235/6 (red), laminin (gray), α-bungarotoxin (green) and Dapi (blue) in TA innervated and
denervated muscles (four independent assays). The white arrows point to endplates. Scale bar, 50 µm (5 µm for enlarged view). cWestern blot analysis of
total and phosphorylated PKB/Akt in control and TSCmKO TA innervated and denervated muscles. Actinin was used as loading control. Representative
image of 4 (14 h to 3d) and 3 (14 and 28d) Ctrl and 3 TSCmKO mice. d–g mRNA levels of Akt1, Akt2 and Akt3 (d, e) and Mtor, Rptor and Rps6 (f, g) in TA
innervated muscle and after 3 (d, f) and 7 (e, g) days of denervation, in TSCmKO and control mice. Levels are relative to Tbp mRNA and to Ctrl innervated
muscle. Values are mean ± s.e.m.; n= 4–6 (Akt2/Akt3) and 3 (all other genes) mice per genotype; *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, two-
way ANOVA with a Tukey’s post-hoc analysis. h Western blot analysis of PKB/Akt and mTORC1 pathways in soleus control and TSCmKO muscles after 7,
14, and 28 days of denervation (n= 3 per group). Western blot quantiﬁcations are shown in Supplementary Table 1. Source Data are provided in the Source
Data File
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Regulation of autophagy after denervation involves mTORC1.
We have previously shown that autophagy blockade by constant
activation of mTORC1 is the main cause for the late-onset
myopathy in TSCmKO mice32. Because of the phenotypic simi-
larities, we wondered whether autophagy impairment would also
underlie denervation-induced myopathy in young TSCmKO
mice. As there are conﬂicting reports on denervation-induced
autophagy changes9,37,38, we ﬁrst characterized autophagic ﬂux in
muscle from control mice at different time points after sciatic
nerve cut. Autophagy markers did not change in control muscle
within the ﬁrst day following denervation (Fig. 3a–d and Sup-
plementary Fig. 3a, b). After 3 days of denervation, autophagy
induction was slightly reduced in TA control muscle, as shown by
increased p62 levels and limited increase in LC3BII/LC3BI ratio
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Fig. 2 Sustained mTORC1 activation impairs muscle response to denervation. a Mass variation for TA and soleus muscles in control (Ctrl) and TSCmKO
(TSC) mice, after 3, 7, 14 and 28 days of denervation, compared to innervated muscle. n= 6 Ctrl, 5/4 TSCmKO (3d TA/Sol), 7/5 (7d TA/Sol) and 3
(14 and 28d) mice per genotype. b, c Fiber size distribution for type IIB (b) and IIA/X (c) ﬁbers in TA innervated (In) and denervated (De, 28d) muscles
from control and TSCmKO mice. n= 3. d Minimum mean ﬁber feret in TA innervated and denervated (28d) muscles from control and TSCmKO mice,
distinguishing type IIB and IIA/X ﬁbers. n= 3. e, f Immunostaining of TA control and TSCmKO muscles for MHCIIA/X (green) and laminin (red). Scale bar,
200 µm. Quantiﬁcation (f) gives the proportion of type IIB ﬁbers in TA innervated and denervated (28d) muscles. n= 3. g, h HE coloration of TA control
and TSCmKO innervated and denervated (28d) muscles (6 independent muscles per group). Open arrows, arrows and arrowheads point to swollen nuclei,
basophilic aggregates and vacuoles, respectively. Scale bar, 50 (g) and 10 (h) µm. i Confocal pictures of lamin (red, top) and nucleolin (red, bottom),
laminin (green) and Dapi (blue) in control and TSCmKO denervated (14 and 28d) muscles (3 independent muscles per group). Arrows indicate giant,
swollen myonuclei. Scale bar, 20 µm. j, k TUNEL staining in control and TSCmKO muscles after 28 days of denervation. The arrow points to a positive,
swollen myonucleus, as shown in the inset with increased brightness. Scale bar, 50 µm. Quantiﬁcation in (k) gives the number of TUNEL-positive nuclei
detected per 100 muscle ﬁbers in control and TSCmKO innervated muscles, and after 28 days of denervation. n= 3 mice/group. l Confocal pictures of
acetylated histones H3 (Lys9; H3K9ac) and H4 (H4ac) and of trimethylated H3 (Lys4, H3K4me3) in denervated (14d) control and TSCmKO muscles
(4 independent muscles per group). The arrow indicates a swollen myonucleus. Scale bar, 10 µm. Values are mean ± s.e.m.; two-tailed unpaired Student’s
t-test (a) or two-way ANOVA with Tukey’s post-hoc test (d, f), *p < 0.05, **p < 0.01, ***p < 0.001. Source Data are provided in the Source Data File
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when blocking the degradation steps with colchicine, compared to
the contralateral, innervated muscle (Fig. 3a–c and Supplemen-
tary Table 1). After prolonged denervation (i.e. 7, 14, and
28 days), p62 levels returned to innervated muscle levels, and
expression of Beclin1, known to be involved in autophagy
induction, increased. Simultaneously, there were high LC3BII
levels, which further increased with colchicine (Fig. 3a–c). These
results indicate that autophagic ﬂux increases at late stages of
denervation in control muscle. Consistently, when using GFP-
LC3-expressing mice39, GFP-LC3-positive puncta accumulated in
muscle ﬁbers after 14 days of denervation, especially near the
endplates (Fig. 3d, e). Thus, denervation induces dynamic tem-
poral regulation of autophagy in TA muscle, whereby autophagy
induction is low at early stages of denervation and strongly
increases at later stages (Fig. 3f). Notably, mTORC1-dependent
inhibitory phosphorylation of Ulk1 (Ulk1P757)32,40 increased in
TA control muscle after 3 days of denervation, while levels of the
active, phosphorylated form Ulk1P317 tended to decrease over
time (Fig. 3a). Ulk1P757 levels remained high after prolonged
denervation, i.e. when autophagy was induced. These results are
consistent with the strong activation of mTORC1 in denervated
TA muscle and point to autophagy inducers promoting autop-
hagic ﬂux after prolonged denervation, despite mTORC1-
dependent Ulk1 phosphorylation (Fig. 3f).
To conﬁrm the role of mTORC1 in autophagy regulation in
denervated TA muscle, we next measured autophagic ﬂux when
modulating mTORC1 activity. First, we injected control mice
with rapamycin 12 h before and 12 h after denervation (Supple-
mentary Fig. 3c). As expected, rapamycin acutely (i.e. at day 1
after denervation), but transiently (effects were lost by 7 days)
inhibited mTORC1 activity (Supplementary Fig. 3d). In control
mice, rapamycin treatment slightly increased autophagy 1 day
after denervation and this effect persisted until day 7 (Supple-
mentary Fig. 3d). We next analyzed RAmKO (Raptor muscle
knockout) muscle, in which mTORC1 is inactive30, and
conﬁrmed that denervation did not change the status of
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mTORC1 and PKB/Akt signaling in the mutant mice (Supple-
mentary Fig. 3e). LC3BII levels were higher in innervated
RAmKO muscle, compared to control muscle, as previously
shown32, and they further increased 3 and 28 days after
denervation (Fig. 3g). Denervation also increased the levels of
p62 in 3-day-denervated RAmKO muscle, but less than in
controls (Fig. 3g). These results show that autophagic ﬂux
increases after denervation in RAmKO TA muscle. Interestingly,
the increased autophagic ﬂux was associated with a stronger
atrophy response than in controls (Fig. 3h, i). Together, these
results indicate that mTORC1 limits autophagy induction,
especially at early time points of denervation in control TA
muscle, and may thereby limit excessive muscle atrophy.
In TSCmKO mice, denervation did not change LC3B from
innervated levels during the ﬁrst week (Fig. 3a). Thereafter,
LC3BII increased in denervated muscle of TSCmKO mice
compared to the contralateral, innervated muscle (Fig. 3a–c).
Consistently, GFP-LC3-positive puncta accumulated in 14-day-
denervated TSCmKO muscle, with autophagic vesicles detected
near endplate regions and in the vicinity of swollen nuclei
(Fig. 3d, e). These data indicate that prolonged denervation can
overcome the mTORC1-mediated blockade of autophagy induc-
tion, even in TSCmKO mice. However, LC3BII levels remained
lower in denervated TSCmKO muscle than in denervated control
muscle, especially upon colchicine treatment, indicating that the
ﬂux is still restricted in TSCmKO mice (Fig. 3a–c). Consistently,
denervation-induced build-up of p62 was stronger in TSCmKO
muscle than in controls (Fig. 3j). To distinguish between the
effects of early- and late-stage autophagy impairment on the
denervation-induced myopathy in TSCmKO mice, we injected
rapamycin 12 h before and 12 h after denervation. This transient
rapamycin treatment slightly induced autophagy at day 1 after
denervation (Supplementary Fig. 3d), and delayed but did not
prevent the accumulation of p62 and the appearance of vacuoles
after 4 weeks of denervation (Fig. 3k-n). Together, these results
show that mTORC1 activation in TA control muscle blocks the
effect of autophagy inducers at early time points of denervation,
but is not sufﬁcient to counteract autophagy induction at later
stages (Fig. 3f). This temporal regulation is essential to prevent
accumulation of damage in the muscle tissue.
Interestingly, autophagy regulation strongly differed in soleus
muscle. There, autophagy induction increased after 1 day of
denervation but was reduced thereafter (Supplementary Fig. 3f-i).
After 3 and 28 days of denervation, LC3BII levels were also
reduced in soleus RAmKO muscle, compared to innervated
muscle (Supplementary Fig. 3j), indicating mTORC1-
independent inhibition of autophagy. In soleus muscle from
TSCmKO mice, autophagy induction after one-day denervation
was prevented as shown by the limited increase in LC3IIB levels
and the accumulation of p62 (Supplementary Fig. 3f, k).
Importantly, transient rapamycin treatment (i.e. 12 h before and
after nerve injury) of TSCmKO mice restored autophagy
induction 1 day after denervation in soleus muscle (Supplemen-
tary Fig. 3l). Rapamycin was also sufﬁcient to prevent the
occurrence of the myopathy in denervated soleus muscle from
TSCmKO mice (Fig. 3m, n and Supplementary Fig. 3k, m).
Hence, blockade of autophagy induction at early stages after
denervation causes damage to accumulate in the soleus muscle
from TSCmKO mice. Altogether, these data demonstrate that
autophagy regulation is dependent on the duration of denervation
and the muscle examined, and is essential for maintaining muscle
homeostasis following denervation.
Sustained mTORC1 activation abolishes endplate main-
tenance. As denervation causes synaptic changes at the neuro-
muscular endplate and in extra-synaptic regions (i.e. >100 µm
away from the endplate region)22,41, we next compared these
changes in TSCmKO and control muscles. Post-synaptic AChRs
remained clustered at the endplates and some extra-synaptic
AChR clusters appeared in control mice (Fig. 4a, b). In TSCmKO
mice, the overall synaptic organization was strongly perturbed in
TA and soleus muscles, 3 weeks after denervation, as shown by
the strong increase in endplate fragmentation, the accumulation
of plaque-like AChR clusters throughout the ﬁbers, and the large
proportion of degenerated endplates (faintly and dispersedly
stained with α-bungarotoxin) (Fig. 4a–d and Supplementary
Fig. 4a-c).
To understand these defects, we determined AChR turnover,
using established procedures20 (see scheme in Supplementary
Fig. 4d). As shown by others16,20,42, AChR turnover strongly
increased in control muscle after denervation (Fig. 4e, f). In
striking contrast, old AChRs persisted at the sarcolemma and
AChR turnover remained low in denervated TSCmKO muscle
(Fig. 4e, f and Supplementary Fig. 4e, f). In parallel, α-
bungarotoxin-positive puncta, observed by live imaging,
Fig. 3 mTORC1 deregulation impairs autophagy dynamics upon denervation. a–c Western blot analysis of autophagic markers in TA control (Ctrl) and
TSCmKO (TSC) muscles after 14 h, 1, 3, 7, 14 and 28 days of denervation (a, representative of 4 (14h-7d) and 3 (14 and 28d) Ctrl and 3 TSCmKO mice per
time point), and after 1, 3 and 14 days of denervation coupled with colchicine (colch.) treatment (b). Quantiﬁcation of LC3BII levels in (b) is given in (c);
n= 3. d, Quantiﬁcation of GFP-LC3-positive vesicles in TA control and TSCmKO innervated (In) muscles, and after 1, 3 and 14 days of denervation (De), in
extra- and sub-synaptic regions. A volume unit (Vol) is 3.2 × 103 µm3. n= 11, 4, 3, 4 Ctrl and 8, 2, 3, 3 TSCmKO (In, 1, 3 and 14d). e Fluorescent images
(three independent assays) of TA control and TSCmKO innervated and denervated (14d) muscles showing GFP-LC3-positive puncta (green), α-
bungarotoxin (Btx, red) and Dapi (blue). Arrowheads point to endplate region; the arrow indicates a swollen myonucleus. Scale bar, 30 µm. f Scheme
illustrating changes in mTORC1 activity and autophagic ﬂux in TA muscle upon denervation. g Western blot analysis of autophagy markers in innervated
TA control and RAmKO (RA) muscles and after 3 and 28 days of denervation. n= 3 Ctrl; 4 and 3 RAmKO (3 and 28d) mice. h Mass variation for TA
muscle from control and RAmKO mice after 3, 7 and 28 days of denervation. n= 6, 3 and 5 Ctrl, 8, 4 and 6 RAmKO mice at 3, 7 and 28d. iMinimum mean
ﬁber feret in TA innervated and denervated (28d) muscles from control and RAmKO mice. n= 3/4 (In) and 5 (De) Ctrl/RAmKO mice. j Fluorescent
images of p62 (red) and laminin (green) for innervated and denervated TA muscles from control and TSCmKO mice. Representative of 3 Ctrl; 4 and 3
TSCmKO mice at 7 and 28 days. Scale bar, 50 µm. k Western blot analysis of p62 in TA denervated (28d) muscles from untreated (−) and rapamycin-
treated (+ ) TSCmKO mice. Representative of 3 muscles per group. l p62 ﬂuorescent images of TA muscle from rapamycin (Rapa)-treated TSCmKO mice
after 7 and 28 days of denervation; 3 independent muscles per group. Scale bar, 50 µm. Compare (l) with untreated TSCmKO mice (j). m, n HE staining of
TA and soleus muscles from untreated and rapamycin-treated TSCmKO mice, after 7 and 28 days of denervation (3 independent muscles per group). Open
arrows and arrows point to abnormal nuclei and vacuoles, respectively. Scale bar, 50 µm. Quantiﬁcation in (n) gives the proportion of vacuolated ﬁbers at
28 days in TA and soleus muscles. n= 6 (untreated TA) and 3 (treated TA; soleus). Western blot quantiﬁcations are shown in Supplementary Table 1.
Values are mean ± s.e.m; two-way ANOVA with Fisher’s (a) or Turkey’s (d, i) post-hoc tests, or two-tailed unpaired Student’s t-test (h, n), *p < 0.05, **p <
0.01, ***p < 0.001, ****p < 0.0001. Source Data are provided in the Source Data File
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accumulated in control denervated muscle (Fig. 4g). The majority
of these AChR-containing puncta represents endocytic vesicles, as
they were positive for the markers Rab5/743 (Supplementary
Fig. 4g, h). Strikingly, the number of these puncta was strongly
reduced in denervated muscle from TSCmKO mice, compared to
controls (Fig. 4g and Supplementary Fig. 4g-i). Together, these
data reveal that sustained mTORC1 activation hampers the
synthesis and internalization of AChRs, and thereby severely
alters the maintenance of neuromuscular endplates upon
denervation.
Sustained mTORC1 activation blocks HDAC4 activation.
Defects observed at the endplates in TSCmKO muscle (i.e. low
AChR turnover, reduced endocytosed AChRs) are the opposite to
those previously reported in Atg7-deﬁcient muscle (i.e. increased
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AChR turnover, accumulation of endocytosed AChRs)41, in
which autophagy is blocked. These different phenotypes suggest
that the endplate defects in TSCmKO muscle are driven by
mechanisms independent of autophagy. As an alternative
mechanism underlying mTORC1-dependent NMJ perturbation,
we examined the HDAC4 signaling, which is involved in the
expression of synaptic genes upon denervation18. Transcript and
protein levels of HDAC4 similarly increased in TA from control
and TSCmKO mice after denervation (Fig. 5a-c). However, while
HDAC4 accumulated speciﬁcally in myonuclei shortly after
denervation in control muscle, HDAC4 was undetectable in
TSCmKO muscle after 7 days of denervation, and only later
accumulated in the cytoplasm and in some giant myonuclei
(Fig. 5d, e). Immunoreactivity of HDAC4-positive myonuclei in
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Fig. 5 Sustained mTORC1 activation hampers HDAC4 signaling upon denervation. a, b Western blot analysis of total and phosphorylated HDAC4 in TA
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ANOVA with Fisher’s (b) or Tukey’s (c, g–o) post-hoc tests, or two-tailed unpaired Student’s t-test (d), *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Western blot quantiﬁcations are shown in Supplementary Table 1. Source Data are provided in the Source Data File
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TSCmKO muscle accumulated at the nuclear envelop rather than
in the nucleoplasm (Fig. 5f and Supplementary Fig. 5a). Given the
high protein levels detected by Western blot, this suggested that
the nuclear import of HDAC4 is impaired in TSCmKO muscle.
To test whether the mislocalization of HDAC4 affected its
activity, we quantiﬁed the expression of its target genes at 1, 3 and
7 days after denervation. Repression of HDAC4 target genes (e.g.
muscle speciﬁc enolase, Eno3; phosphofructokinase, Pfkm; MHC
type 2b, Myh4) was delayed or blunted in denervated TA
TSCmKO muscle compared to controls (Fig. 5g, h). Similarly,
induction of HDAC4 indirect targets, including genes encoding
myogenin (Myog), MyoD (Myod1), AChR subunits α and γ
(Chrna1/g), and MHC 2a (Myh2), was delayed at day 1 post-
injury and/or strongly reduced after 3 and 7 days of denervation
in TSCmKO muscle, as compared to controls (Fig. 5i-k). These
results are consistent with an impaired function of HDAC4 in
mutant muscle. Interestingly, transcript levels of Mitr, an
alternatively spliced isoform of HDAC9, which represses Myog
and is a target of HDAC428, were strongly increased in innervated
TA TSCmKO muscle (Fig. 5l, m). This may contribute to the
altered regulation of myogenic and synaptic genes in mutant
muscle. Notwithstanding, Mitr levels were efﬁciently reduced
upon denervation in mutant muscle, and expression of the
HDAC4 target Dach2, which encodes another repressor of
Myog28, was blunted in both innervated and denervated TA
TSCmKO muscles (Fig. 5l, m). Of note, similar HDAC4
deregulation was detected in soleus muscle from TSCmKO mice
(Supplementary Fig. 5b-e).
HDAC4 and FoxO signaling contribute to the up-regulation of
atrogenes at 3 and 7 days post-denervation, respectively6. As
previously shown31,32, expression of the atrogenes Trim63 and
Fbxo32 was high in TSCmKO innervated muscle (Fig. 5n, o).
After denervation, the fold change in atrogene transcript levels
was reduced in TSCmKO muscle at 3 days (Trim63: FC, 3.95 ±
0.41 in Ctrl, 2.74 ± 0.57 in TSCmKO; Fbxo32: FC, 2.87 ± 0.35 in
Ctrl, 1.90 ± 0.40 in TSCmKO; n= 3), but rather increased at
7 days (Trim63: FC, 1.94 ± 0.30 in Ctrl, 2.90 ± 0.15 in TSCmKO,
p= 0.04; Fbxo32: FC, 1.72 ± 0.23 in Ctrl, 2.10 ± 0.22 in TSCmKO;
n= 3) compared to controls (Fig. 5n, o). This is consistent with a
combined, defective HDAC4 function and high FoxO activation
in mutant denervated muscle (Supplementary Fig. 5f). Similarly,
changes in the expression of autophagy genes were limited in
TSCmKO denervated muscle (Fig. 5n, o), which may be related to
the HDAC4 defect44.
As Ca2+/calmodulin-dependent protein kinases II (CaMKIIs)
control the trafﬁcking of class II HDACs, we next examined
CaMKII activity in TSCmKO muscle. Increase in HDAC4
expression upon denervation was associated with increased levels
of the CaMKII-targeted, phosphorylated (Ser247 and 632) forms
of HDAC4 in control and TSCmKO muscles (Fig. 5a). Levels of
CaMKII isoforms and of their active, auto-phosphorylated forms
(Ser287) were unchanged in control muscle after denervation, or
even increased at late stages (Supplementary Fig. 5g). Further-
more, the transcript levels of Camk2d and Camk2bM were
unchanged at 3 days of denervation and up-regulated after 7 days
(Supplementary Fig. 5h, i). Interestingly, expression of the
muscle-speciﬁc isoform CaMKIIβM was strongly reduced in
TSCmKO muscle, while CaMKIIγ/δ levels were similar to
controls (Supplementary Fig. 5g-i). Thus, sustained mTORC1
activation in TSCmKO muscle inhibits the nuclear import and
activity of HDAC4, likely independently of CaMKIIs.
Acute mTORC1 activation impairs endplate remodeling. To
test whether HDAC4 deregulation is a consequence of the myo-
pathic changes in TSCmKO mice, we generated a new mouse
model (herein called iTSCmKO mice) that allows tamoxifen-
induced deletion of Tsc1 in adult skeletal muscle. One week after
tamoxifen-induced recombination, mTORC1 was active, leading
to progressive feedback inhibition of PKB/Akt, as previously
described in TSCmKO mice31,32 (Fig. 6a and Supplementary
Fig. 6a). This acute activation of mTORC1 caused some resistance
to denervation-induced atrophy in TA but not soleus muscle
(Fig. 6b). Importantly, after 1 month of denervation, iTSCmKO
mice reproduced the alterations observed in TSCmKO muscle (e.
g. vacuoles, giant nuclei, loss of type IIA/X ﬁbers) (Fig. 6c), with
no signs of myopathy in the contralateral, innervated muscle
(Supplementary Fig. 6b). As in TSCmKO mice, HDAC4 levels
strongly increased upon denervation in iTSCmKO muscle to
levels similar to control denervated muscle (Fig. 6d). This
response did not depend on whether recombination of ﬂoxed
Tsc1 was induced for only 3 days (i.e. with limited changes in
mTORC1-PKB/Akt activity – referred to as “short”) or more than
1 week (referred to as “long”) before denervation. Notably,
despite high protein levels, HDAC4 did not accumulate in
myonuclei of denervated iTSCmKO muscle with “long recom-
bination”, but did accumulate after “short recombination”
(Fig. 6e, f). Similarly, AChR turnover increased upon denervation
in control muscle and iTSCmKO muscle with “short recombi-
nation”, but remained low in iTSCmKO muscle with “long
recombination” (Fig. 6g, h). These results provide additional
evidence that the impaired nuclear import of HDAC4 may be
responsible for the endplate defects in TSCmKO mice. They
further indicate that these defects are not a consequence of a pre-
existing myopathy, but rather the consequence of sustained
mTORC1 activation.
HDAC4 defect contributes to endplate loss in TSCmKO
muscle. Maintenance of neuromuscular endplates upon dener-
vation involves the up-regulation of synaptic genes in sub- and
extra-synaptic regions45,46. To conﬁrm the role of HDAC4 in
endplate degeneration in TSCmKO mice, we ﬁrst analyzed
HDAC4 localization throughout muscle ﬁbers. While HDAC4
was undetectable in single ﬁbers isolated from innervated muscle,
it accumulated strongly in sub- and extra-synaptic myonuclei of
control muscle upon denervation (Fig. 7a). Similarly, myogenin
was detected in both sub- and extra- synaptic nuclei in dener-
vated control ﬁbers (Fig. 7b). In contrast, HDAC4 and myogenin
were detected neither in sub- nor in extra-synaptic myonuclei of
denervated TSCmKO muscle (Fig. 7a, b). Similar results were
obtained using immunostaining on muscle sections (Supple-
mentary Fig. 7a, b). As HDAC4 has been shown to inhibit
HDAC9 and thereby to increase histone acetylation upon
denervation26, we next analyzed levels of histone acetylation in
control and TSCmKO muscles. While acetylation of histone H4
increased upon denervation in both sub- and extra-synaptic
regions in control muscle, the signal remained low in TSCmKO
denervated ﬁbers (Fig. 7c). A similar difference between control
and TSCmKO muscles was observed with acetylated histone H3
(Supplementary Fig. 7c). These results suggest that HDAC4
induction contributes to synaptic gene up-regulation in sub- and
extra-synaptic regions, and they show that this activity is abro-
gated in TSCmKO muscle.
To assess whether HDAC4 deregulation is responsible for the
defective endplate maintenance in TSCmKO and iTSCmKO
muscles, we next electroporated plasmids encoding GFP-tagged
HDAC4 into denervated mutant muscle. Although the nuclear
accumulation of the electroporated HDAC4 was less in TSCmKO
ﬁbers than in control muscle (Fig. 7d and Supplementary Fig. 7d),
HDAC4 overexpression was sufﬁcient to drive some HDAC4 into
myonuclei, including sub-synaptic myonuclei, in TSCmKO
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muscle (Fig. 7e). Thus, we next combined HDAC4 overexpression
with the measurement of AChR turnover in denervated TSCmKO
muscle. Importantly, AChR turnover was strongly increased in
HDAC4-transfected ﬁbers from TSCmKO muscle, but remained
low in GFP-electroporated mutant ﬁbers (Fig. 7f, g). These results
indicate that defective HDAC4 activity contributes to the loss of
neuromuscular endplates upon denervation in TSCmKO muscle.
PKB/Akt activation promotes HDAC4 and endplate remodel-
ing. Since control and TSCmKO muscles both show strong
mTORC1 activation upon denervation, but differ in the activation
state of PKB/Akt (Fig. 8a), we tested whether PKB/Akt inhibition
would be responsible for HDAC4 defects and endplate degen-
eration in TSCmKO muscle. To test this, we used transgenic mice
(Akt1-TG mice) expressing an active, myristoylated form of Akt1,
fused with EGFP and ERT2. In the absence of tamoxifen, the
fusion protein is immediately degraded, while the binding of
tamoxifen to ERT2 renders the protein stable. Thus, injection of
tamoxifen leads to the immediate activation of PKB/Akt, which in
turn strongly activates mTORC1 (Fig. 8b). Hence, mTORC1
activation is similar in Akt1-TG and TSCmKO muscles, while
PKB/Akt is active in Akt1-TG muscle, but inhibited in TSCmKO
muscle (Fig. 8a). Activation of Akt1 for 2 weeks was sufﬁcient to
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Fig. 6 Acute mTORC1 activation impairs HDAC4 function and limits AChR turnover. aWestern blot analysis of total and phosphorylated levels of PKB/Akt
and S6 in TA innervated and 3-day-denervated control (Ctrl) and iTSCmKO (iTSC) muscles, without tamoxifen treatment (−), or 6, 13, and 24 days after
recombination induction (Rec). n= 3 (untreated, 6 and 13d) and 5 (28d) iTSCmKO mice. b Mass variation for TA and soleus (Sol) muscles in control and
iTSCmKO mice, after 28 days of denervation, as compared to contralateral innervated muscle. n= 3 per group. c HE coloration (top panel) and ﬂuorescent
pictures of MHCIIA/X (bright/dark green) and laminin (red) immunostaining (lower panel) of TA denervated (28d) muscle from control and iTSCmKO
mice. Representative of 3 independent muscles per group. Arrows, arrowhead and open arrows point to intracellular aggregates, vacuoles and abnormal
giant nuclei, respectively. Scale bar, 50 (top) and 200 (bottom) µm. d Western blot analysis of HDAC4 in innervated and denervated (3d) control and
iTSCmKO mice after short (sh) or long (lg) recombination induction. e, f Fluorescent pictures of HDAC4 (red) and laminin / GFP (green) of 3-day-
denervated TA muscle from control and iTSCmKO mice with short or long recombination induction. Arrows point to HDAC4-positive myonuclei. Scale bar,
100 µm. Quantiﬁcation in (f) gives the proportion of HDAC4-positive myonuclei. n= 5 Ctrl, 3 (short) and 5 (long) iTSCmKO muscles. g, h AChR turnover
quantiﬁcation for control and iTSCmKO mice with short or long recombination induction. n= 4/5/3 (In) and 7/3/3 (De) Ctrl, short and long iTSCmKO
muscles. Representative pictures of “old” (green) and “new” (red) AChRs is given in (h). GFP appears in gray in iTSCmKO ﬁbers. Scale bar, 50 µm. All
values are mean ± s.e.m; two-tailed unpaired Student’s t-test (b), or one- (f) or two- (g) way ANOVA with Tukey’s post-hoc test, *p < 0.05, **p < 0.01,
***p < 0.001, ****p < 0.0001. Western blot quantiﬁcations are shown in Supplementary Table 1. Source Data are provided in the Source Data File
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increase muscle mass in innervated muscle, and to limit muscle
mass loss after denervation (Supplementary Fig. 8a), as previously
reported47. This effect was related to the resistance to
denervation-induced atrophy of type IIA/X ﬁbers in Akt1-TG
muscle (Supplementary Fig. 8b, c). After 14 days of denervation,
Akt1-TG muscle showed only minor myopathic signs and there
was no change in ﬁber type proportion (Fig. 8c and Supple-
mentary Fig. 8d), in contrast to TSCmKO muscle. As in controls,
HDAC4 was undetectable by immunostaining in innervated
Akt1-TG muscle (Fig. 8d), despite slightly higher protein levels
(Fig. 8e). Importantly, protein levels of HDAC4 strongly
increased after denervation in Akt1-TG muscle, and it accumu-
lated in myonuclei, with higher signal intensity compared to
control muscle (Fig. 8d–f). Expression of HDAC4 targets was
efﬁciently repressed after denervation in mutant muscle (Fig. 8g).
Inversely, levels of Myog and Chrng were increased in Akt1-TG
innervated muscle, compared to control, and reached similarly
high levels in control and mutant muscles after denervation
(Fig. 8h). Hence, in contrast to the blunted activation of HDAC4
detected in TSCmKO and iTSCmKO muscles, PKB/Akt activa-
tion promotes HDAC4 signaling, despite the acute activation of
mTORC1.
As HDAC4 defect contributes to endplate degeneration in
TSCmKO denervated muscle, we examined synaptic changes in
Akt1-TG muscle. Endplate organization in Akt1-TG mice looked
similar to controls both in innervated and denervated muscles
(Supplementary Fig. 8e-g). Interestingly, AChR turnover was
higher in the innervated muscle of Akt1-TG mice than in controls
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and further increased after denervation (Fig. 8i, j). This indicates
that acute mTORC1 activation, when combined with PKB/Akt
activation, does not impinge on synaptic changes upon denerva-
tion and, that the defects observed in TSCmKO and iTSCmKO
muscles are rather due to PKB/Akt inhibition (Fig. 8a).
To conﬁrm the role of PKB/Akt in HDAC4 regulation, we
lastly co-electroporated C2C12 myotubes with plasmids encoding
the wild-type form or a nuclear mutant (HDAC4-3SA) of GFP-
tagged HDAC427, together with plasmids coding for either a
wild-type, a myristoylated (i.e. active) or an inhibited form of
HA-tagged Akt148,49. Electroporation was done at 6 days of
differentiation to avoid any effect on cell fusion and growth.
Wild-type HDAC4 localized in cytoplasm and/or nuclei, while
HDAC4-3SA was only detected in nuclei (Fig. 9a). Co-
electroporation of wild-type HDAC4 with the inhibited form of
Akt1 did not modify the subcellular localization of HDAC4,
compared to cells electroporated with HDAC4 alone (Fig. 9a, b).
In contrast, the proportion of myotubes with only cytoplasmic
HDAC4 was decreased when they were co-transfected with wild-
type Akt1, and even more so with the myristoylated form of Akt1
(Fig. 9a, b). This shows that activation of PKB/Akt promotes the
nuclear import of HDAC4 in myotubes. Altogether, these results
indicate that PKB/Akt activation is essential for the nuclear
import and the activity of HDAC4 in muscle after denervation,
and thereby for the maintenance and remodeling of neuromus-
cular endplates (Fig. 9c).
Discussion
Nerve injury leads to major changes in skeletal muscle, including
remodeling of the post-synaptic apparatus and loss of muscle
mass. The molecular mechanisms responsible for these changes
remain largely unknown. We here establish that mTORC1 and
PKB/Akt are activated upon denervation, and that a tight reg-
ulation of their activity is required to maintain muscle
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homeostasis. Sustained or acute mTORC1 activation leads to
severe muscle alterations after nerve injury, related to autophagy
impairment, and abrogates physiological muscle responses to
denervation (i.e. ﬁber type switch, gene up-regulation, increased
AChR turnover). We show that this effect is caused by inhibition
of PKB/Akt, which abrogates the nuclear import of HDAC4 and,
thereby synaptic gene up-regulation in the denervated muscle.
Previous reports suggested that denervation activates
mTORC1, although its role in denervation-induced atrophy
remains debated6,9. Similarly, some studies pointed to an acti-
vation of PKB/Akt upon denervation, while Tang et al. reported
that the signaling is inhibited6,12–15. We now establish that
denervation triggers activation of both mTORC1 and PKB/Akt,
accompanied by a transcriptional up-regulation of the Akt1,
Mtor, and Rptor genes. We further demonstrate that to maintain
homeostasis, mTORC1 activation must be tightly controlled in
the denervated muscle. This effect is dependent on the dynamic
regulation of autophagic ﬂux upon denervation. In particular, in
TA muscle, mTORC1 activation inhibits autophagy at early
stages, and may thereby limit excessive muscle atrophy. In con-
trast, at late stages, autophagy induction increases despite
mTORC1 activation and the subsequent inhibition of Ulk1,
which likely involves alternative pathways triggering autophagy
induction50. In soleus muscle, autophagy is induced shortly after
denervation and reduced later independent of mTORC1. Hence,
autophagy re-induction at late stages may be an adaptive
mechanism to cope with the increase in protein synthesis related
to mTORC1 activation detected in TA, but not soleus, muscle.
Constant activation of mTORC1 by genetic manipulation restricts
autophagy in TA and soleus denervated muscles (especially at late
and early time points, respectively), and leads to an accumulation
of autophagy-related alterations. Inversely, mTORC1 inactivation
increases autophagic ﬂux in denervated TA muscle, which cor-
relates with an exacerbated muscle atrophy.
Importantly, besides their role in muscle homeostasis, we
unveil a determinant, yet-unknown function of mTORC1 and
PKB/Akt in muscle physiology. Although mTORC1 becomes
activated in control muscle after denervation, constant activation
of mTORC1 with a consecutive inhibition of PKB/Akt (TSCmKO
and iTSCmKO mice) abrogates several hallmarks of denervation.
In this case, HDAC4 nuclear accumulation was hampered, while
its protein levels efﬁciently increased. Several kinases have been
shown to modulate HDAC4 nuclear import, such as
CaMKIIs51,52 and PKA/C53–55. We now show that activation of
PKB/Akt is sufﬁcient to drive HDAC4 into myonuclei in cultured
myotubes, and is required for HDAC4 nuclear accumulation in
denervated muscle. The mislocalization of HDAC4, and the
subsequent deregulation of its target genes, are likely responsible
for several defects observed in TSCmKO and iTSCmKO dener-
vated muscles. In particular, the abnormal ﬁber type switch in
denervated TSCmKO muscle correlates with the abnormal reg-
ulation of Myh4 and Myh2, two targets of HDAC4. Similarly,
recent studies suggested that the main driver for AChR destabi-
lization after nerve injury is the incorporation of new AChRs at
the membrane18. Although not yet clearly established, it is likely
that the up-regulation of synaptic genes in both sub- and extra-
synaptic regions supports the increased turnover of synaptic
proteins at the neuromuscular endplate, and thereby its main-
tenance. Consistently, we show that HDAC4 is detected in both
sub- and extra-synaptic myonuclei upon denervation. Moreover,
together with the defective nuclear import of HDAC4, the
induction of myogenic and synaptic genes and the increase in
AChR turnover were hampered in TSCmKO muscle. HDAC4
overexpression was sufﬁcient to drive HDAC4 nuclear accumu-
lation in sub- and extra-synaptic myonuclei, and to restore AChR
turnover in TSCmKO muscle. Up-regulation of synaptic genes
and increased AChR turnover in innervated Akt1-TG muscle
further support the role of PKB/Akt in the regulation of HDAC4,
although one cannot rule out the contribution of HDAC4-
independent mechanisms in the effects observed. Based on our
results and consistent with previous reports27,28,56, it is also likely
that HDAC4-independent mechanisms contribute to Mitr/Dach2
repression in muscle and, that alternative effectors mediate the
effect of HDAC4 on synaptic gene regulation upon denervation.
In conclusion, our work has unraveled important roles of the
mTORC1 and PKB/Akt pathways in the muscle response to
denervation, which includes the control of muscle homeostasis, as
well as the maintenance of neuromuscular endplates. PKB/Akt-
dependent regulation of HDAC4 is an important contributor of
this response. Hence, one should consider the deregulation of the
PKB/Akt-mTORC1 axis as a potent factor in the loss of neuro-
muscular integrity in neuromuscular diseases and systemic
pathological conditions, such as aging.
Methods
Animals. Generation and genotyping of RAmKO, TSCmKO, and GFP-LC3
transgenic mice were described previously30,39. Control mice for RAmKO and
TSCmKO mice were littermates that were ﬂoxed for Rptor (gene encoding raptor)
or Tsc1, but did not express Cre-recombinase. Inducible TSCmKO mice
(iTSCmKO) were obtained by breeding Tsc1-ﬂoxed mice with mice expressing the
Cre recombinase in skeletal muscle upon tamoxifen injection (inducible modiﬁed
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HSA promoter, HSA-MerCreMer57). Recombination was induced by 5 tamoxifen
injections, and denervation was performed from 3 (short) to 10–21 (long) days
after recombination induction. Control mice for iTSCmKO mice were littermates
that were ﬂoxed for Tsc1, treated with tamoxifen, but did not express Cre-
recombinase. Inducible Akt1-TG mice were developed by recombinase mediated
cassette exchange into the ROSA 26 locus using a modiﬁed embryonic stem cell
line. A neomycin-resistant inducible Akt1 cassette was cloned between lox 511 and
lox P sites, which allowed cassette exchange in the presence of Cre. After cassette
exchange, neomycin-resistant cells were used for microinjection into blastocysts
and eventual implantation into surrogate females to generate the inducible Akt1-
TG line. Akt1-TG mice were pre-treated with tamoxifen the day before denerva-
tion, and were then treated over the period of experiment. Controls for Akt1-TG
mice were littermate wild-type mice treated with tamoxifen. Sciatic nerve cut and
in vivo muscle electroporation were conducted as described previously31,58. Upon
denervation, muscle mass variation (%) was calculated as the difference of the mass
of the denervated and innervated muscles (from the contralateral leg), normalized
to the mass of the innervated muscle. In some experiments, mice were intra-
peritoneally injected with colchicine (Sigma, 0.4 mg/kg) or rapamycin (LC
Laboratories, 1.5 mg/kg)47,59. Mice were maintained in a conventional facility with
a ﬁxed light cycle (23 °C–12 h dark-light cycle). All animal studies were performed
in accordance with the European Union guidelines for animal care and approved
by the Swiss authorities.
Cell culture. C2C12 cells were obtained from ATCC (CRL-1772). Myoblasts were
grown in Dulbecco’s modiﬁed Eagle’s medium (DMEM; Sigma, D5796) supple-
mented with 20% fetal bovine serum and 1% penicillin-streptomycin (pen/strep).
They were differentiated into myotubes by switching to differentiation medium
(DMEM, 2% horse serum, 1% pen/strep). Electroporation of myotubes was done
after 6 days in differentiation medium, using NEPA21 electroporator (NEPAgene)
with the CUY900-13-3-5 Cell-Culture-Plate Electrode, in 24-well plate. Cells were
ﬁxed, 24 hr after electroporation, with 2% paraformaldehyde (PFA), 2% sucrose,
washed with PBS (pH 7.4) and 0.1 M glycine, and analyzed by immunostaining.
Transcript expression analyses. Total RNA was extracted with the RNeasy
Fibrous Tissue Mini Kit (Qiagen). Quantitative PCR was performed on DNAse-
treated RNA, reverse transcribed to cDNA using the SuperScript III First-Strand
Synthesis System (Invitrogen), ampliﬁed with the Applied Biosystem Power Sybr
Green Master Mix. Data were analyzed using StepOne software and normalized to
Tbp expression. Primers are listed in Supplementary Table 2.
Antibodies. All primary antibodies were used at 1/1000 for Western blot; when the
antibody was used for IHC, the dilution is indicated in the list. The following
antibodies were used: PKB/Akt (#9272), Phospho-AktSer473 (#9271), Phospho-
AktSer308 (#9275), p70 S6 kinase (#9202), Phospho-p70 S6 kinaseThr389 (#9205), S6
Ribosomal Protein (#2217), Phospho-S6 Ribosomal ProteinSer235/6 (#2211; 1/100
for IHC), Phospho-S6 Ribosomal ProteinSer240 (#2215; 1/100 for IHC), LC3B
(#2775), Ulk1 (#8054), Phospho-Ulk1Ser757 (#6888), Phospho-Ulk1Ser317 (#6887)
Beclin1 (#3495), HDAC4 (#15164 and #7628; 1/5000 for IHC), Phospho-
HDAC4Ser246 (#3443), Phospho-HDAC4Ser632 (#3424), nucleolin (#14574; 1/500
for IHC), endonuclease G (#4969), Gadd45 (#4632), Rab5 (#2143; 1/100 for IHC),
Rab7 (#9367; 1/100 for IHC) from Cell Signaling; α-actinin (A5044) and Neuro-
ﬁlament 200 (N4142; 1/2000 for IHC) from Sigma; p62 (GP62C; 1/300 for IHC)
from Progen; myogenin (F5D; 1/100 for IHC), Myosin Heavy Chain types I
(A4.840; 1/300 for IHC), IIA/IIX (A4.74; 1/300 for IHC), IIB (BF-F3; 1/300 for
IHC) from the Developmental Studies Hybridoma Bank; Laminin (ab11575 and
ab11576; 1/500 for IHC) from Abcam; Lamin B from Santa Cruz (C-20); Synap-
tophysin (A0010; 1/200 for IHC) from Dako; acetylated Histones H3 (17–658; 1/
1000 for IHC) and H4 (06–598; 1/1000 for IHC), Trimethyl Histone H3 (Lys4 -
17–614; 1/500 for IHC) from Millipore Merck.
Western blotting. TA and soleus muscles were frozen and powdered in liquid
nitrogen. They were lysed in RIPA buffer (50 mM Tris HCl pH8, 150 mM NaCl,
1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 1% Triton-X, 10% glycerol) with
protease and phosphatase inhibitor cocktail tablets (Roche). Cell lysates were
incubated on ice for 2 h, sonicated two times for 10 s and centrifuged at 10,000 × g
for 20 min at 4 °C. Cleared lysates were used to determine total protein amount
(BCA Protein Assay, Pierce). Proteins were separated in 7 or 15% polyacrylamide
SDS gels and transferred to nitrocellulose membrane.
Histology analyses. Muscles were dissected and frozen in liquid nitrogen-cooled
isopentane; eight µm muscle cryosections were used for histology analyses. Cryo-
stat sections were stained with Hematoxylin/Eosin (HE) according to classical
methods60. Light microscopy was performed using an upright microscope (Leica
and Olympus), and pictures were captured using a monochrome camera (DS-Ri1,
Nikon).
For MHC staining, sections were ﬁxed with 100% methanol, followed by
microwave oven antigen retrieval in citric acid. For HDAC4 and FoxO3 staining,
sections were ﬁxed with PFA 4%. Sections were then blocked with 3% IgG free
bovine serum albumin and AfﬁniPure Mouse IgG Fab Fragments (Jackson
ImmunoResearch). They were incubated sequentially with primary and secondary
ﬂuorescent antibodies (Invitrogen) and mounted in Vectashield DAPI (Vector).
TUNEL staining was done with the In Situ Cell Death Detection Kit, Fluorescein
(Roche). Images were captured using the analySIS software (Soft Imaging System)
with a ﬂuorescent Leica microscope. Fiber size distribution was determined based
on laminin immunostaining (analySIS software).
For GFP-LC3 detection, mice were perfused with 4% PFA in PBS. TA and soleus
muscles were excised, ﬁxed in the same ﬁxative and treated with 30% sucrose in
PBS overnight. Cryosections were stained with α-bungarotoxin-Alexa555
(Invitrogen), washed with PBS and mounted. Images were recorded using a
Leica confocal microscope with 63x objective. The number of GFP-LC3 puncta
was counted on 3D reconstructed images with the Imaris software. Six image
stacks in extra-synaptic regions, and 15 sub-synaptic ﬁelds were quantiﬁed
for each muscle. The average numbers of GFP-LC3 puncta per volume unit
(20.46 × 20.46 × 7.55 µm3) were used for statistical analyses. All GFP
quantiﬁcations were done in a double-blind way.
Staining of muscle bundles and single isolated ﬁbers. To analyze NMJ orga-
nization, muscles were bathed ex vivo (2 µg/ml) with α-bungarotoxin-Alexa555
(Invitrogen) for 30min, before being washed and ﬁxed with 4% PFA. Muscle
bundles were cut, permeabilized in PBS, 1% Triton-X100, and blocked in PBS, 1%
BSA, 0.1% Triton-X100. Bundles were then successively incubated with primary
antibodies against Neuroﬁlament and Synaptophysin (to stain pre-synaptic com-
partment), and the corresponding secondary antibodies (Invitrogen). When com-
bined with electroporation, mice were perfused with 4% PFA in PBS, and muscle
were post-ﬁxed for 15min, before processing muscle bundles. Endplates were
considered as degenerated when they showed no obvious dense AChR-positive
dense fragment, or when more than 30 fragments were observed. Immunostaining
on single ﬁbers was done on ﬁbers isolated from PFA-ﬁxed muscle and permea-
bilized with PBS, 3% BSA, 0.5% Triton26. Primary antibodies were incubated
overnight, followed by over day washing, and incubation with the corresponding
secondary antibodies (Invitrogen) and ﬂuorescent α-bungarotoxin to distinguish
extra- and sub-synaptic regions. More than 30 ﬁbers were used per analysis. Images
were recorded using a Leica confocal microscope with ×40 to ×100 objectives.
AChR turnover. AChR turnover was assessed by injecting α-bungarotoxin-
Alexa647 and -Alexa555 (25 pmoles - Invitrogen) into TA/EDL muscles at days 1
and 10, respectively (5 and 14 days after nerve cut when combined with dener-
vation). Analysis was conducted in living muscle as previously done20,41 or with
muscle bundles. Analysis of ﬁxed whole-mount preparations of TA and EDL
muscle ﬁber bundles gave similar results to live imaging of muscle (see Supple-
mentary Fig. 4e, f). For turnover quantiﬁcation, images were recorded using a Leica
confocal microscope with ×63 objective. Pixel dominance (old or new receptors)
was calculated using Fiji and Matlab software20,41.
Images and statistical analyses. Images were analyzed with the analySIS (Soft
Imaging System), Imaris, Fiji and Matlab software. Results are expressed as mean ±
SEM of independent animals, with n (number of individual experiments) ≥3.
Statistical comparison was performed using two-tailed Student’s t-test or one/two-
way ANOVA test, with prior log transformation of the data, dependent on the
conditions. A 0.05 level of conﬁdence was accepted for statistical signiﬁcance. All
p values are provided in the Source Data File27,48,49.
Reporting Summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The data presented in this study are available from the corresponding authors upon
reasonable request. The source data underlying Figs. 1a,c–h, 2a-d,f,k, 3a-d, g-i, k, n, 4c, d,
f, g, 5a–d, g–o, 6a, b, d, f, g, 7g, 8b, e–i, 9b, and Supplementary Figs 1a,d, 2a-d, g, l-o, 3a,
d-h, j, l, m, 4b, c, e, f, h, i, 5b, d, e, g-i, 8a-d, f, g are provided as a Source Data ﬁle.
Code availability
The code used for AChR turnover analysis has been described previously20,41, and is
available from the authors upon reasonable request.
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